Vertex Pharmaceuticals (VRTX) balance sheet
NASDAQ · Healthcare · Biotechnology · 6,400 employees · CEO Reshma Kewalramani
- Price
- $558.88 +3.50%
- Market cap
- $142B
- Enterprise value
- $137B
- Last report
- Q2 '26 filed 2026-08-04
- Next report
- 2026-11-02 EPS est. $4.82
At the end of Q2 '26 Vertex Pharmaceuticals (VRTX) held $7.85B in cash and short-term investments against $1.98B of debt incl. leases. Total assets $27.4B, total liabilities $7.18B, shareholders' equity $20.2B.
Balance sheet
| Balance sheet | Trend | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & equivalents | $11.1B | $10.4B | $9.16B | $4.58B | $5.24B | $4.57B | $4.67B | $4.97B | $4.94B | $5.09B | $5.49B | $6.14B | |
| Short-term investments | $818M | $849M | $1.01B | $1.22B | $1.29B | $1.55B | $1.53B | $1.41B | $1.35B | $1.52B | $1.75B | $1.71B | |
| Receivables | $1.54B | $1.56B | $1.79B | $1.66B | $1.75B | $1.61B | $1.81B | $1.89B | $1.95B | $2.05B | $2B | $2.13B | |
| Inventory | $689M | $739M | $813M | $915M | $1.08B | $1.21B | $1.36B | $1.5B | $1.63B | $1.69B | $1.77B | $1.77B | |
| Other current assets | $540M | $86.1M | $511M | $575M | $449M | $207M | $643M | $652M | $709M | $749M | $721M | $0 | |
| Current assets | $14.7B | $14.1B | $13.3B | $8.94B | $9.8B | $9.6B | $10B | $10.4B | $10.6B | $11.2B | $11.7B | $12.5B | |
| Property, plant & equipment (net) | $1.43B | $1.45B | $1.49B | $1.77B | $2.51B | $2.58B | $2.63B | $2.65B | $3.02B | $3.08B | $1.61B | $3.33B | |
| Long-term investments | $1.7B | $2.5B | $4.38B | $4.39B | $4.7B | $5.11B | $5.16B | $5.65B | $5.72B | $5.81B | $5.75B | $5.79B | |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | $1.09B | |
| Intangible assets | $604M | $840M | $835M | $838M | $832M | $826M | $441M | $436M | $430M | $424M | $419M | $413M | |
| Deferred tax assets | $1.73B | $1.81B | $1.96B | $2.19B | $2.31B | $2.33B | $2.54B | $2.71B | $2.94B | $3.4B | $2.95B | $3.01B | |
| Other non-current assets | $475M | $895M | $876M | $916M | $990M | $999M | $1.01B | $1.08B | $1.1B | $1.14B | $2.94B | $1.25B | |
| Non-current assets | $7.03B | $8.59B | $10.6B | $11.2B | $12.4B | $12.9B | $12.9B | $13.6B | $14.3B | $14.9B | $14.8B | $14.9B | |
| Total assets | $21.7B | $22.7B | $23.9B | $20.1B | $22.2B | $22.5B | $22.9B | $24B | $24.9B | $26.1B | $26.5B | $27.4B | |
| Liabilities | |||||||||||||
| Accounts payable | $376M | $365M | $351M | $328M | $396M | $413M | $445M | $442M | $420M | $462M | $489M | $430M | |
| Accrued expenses | $2.91B | $2.32B | $2.8B | $2.94B | $3.22B | $2.36B | $2.95B | $3.27B | $3.61B | $398M | $2.98B | $3.18B | |
| Short-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $82.8M | $0 | $0 | |
| Taxes payable | $0 | $99.5M | $0 | $0 | $0 | $161M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Deferred revenue | $0 | $170M | $0 | $0 | $0 | $207M | $0 | $0 | $0 | $172M | $0 | $0 | |
| Other current liabilities | $316M | $50.7M | $649M | $279M | $358M | $31.4M | $386M | $425M | $442M | $2.75B | $407M | $329M | |
| Current liabilities | $3.6B | $3.55B | $3.8B | $3.55B | $3.97B | $3.56B | $3.78B | $4.14B | $4.48B | $3.86B | $3.88B | $3.94B | |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.85B | $0 | $0 | |
| Lease obligations (non-current) | $745M | $725M | $721M | $933M | $1.7B | $1.66B | $1.65B | $1.53B | $1.83B | $1.95B | $1.99B | $1.98B | |
| Deferred tax liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.31B | $0 | $0 | |
| Other non-current liabilities | $869M | $878M | $854M | $877M | $933M | $902M | $952M | $1.2B | $1.23B | -$1.49B | $1.26B | $1.26B | |
| Non-current liabilities | $1.61B | $1.6B | $1.57B | $1.81B | $2.64B | $2.56B | $2.6B | $2.72B | $3.07B | $3.62B | $3.24B | $3.24B | |
| Total liabilities | $5.21B | $5.15B | $5.37B | $5.36B | $6.61B | $6.12B | $6.38B | $6.86B | $7.54B | $7.48B | $7.12B | $7.18B | |
| Equity | |||||||||||||
| Common stock & paid-in capital | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.5M | $2.5M | $2.5M | $2.5M | |
| Retained earnings | $9.17B | $10.1B | $11.2B | $7.65B | $8.69B | $9.61B | $10.3B | $11.3B | $12.4B | $13.6B | $14.6B | $15.7B | |
| Accumulated other comprehensive income | -$3M | -$14.3M | $17.3M | $22.5M | $28.8M | $128M | $68.1M | -$101M | -$64.5M | -$15.9M | $24.8M | $48.5M | |
| Shareholders' equity | $16.5B | $17.6B | $18.5B | $14.8B | $15.6B | $16.4B | $16.5B | $17.2B | $17.3B | $18.7B | $19.4B | $20.2B | |
| Debt | |||||||||||||
| Total debt (incl. leases) | $745M | $808M | $721M | $933M | $1.7B | $1.75B | $1.65B | $1.53B | $1.83B | $3.88B | $1.99B | $1.98B | |
| Net debt (debt - cash) | -$10.4B | -$9.56B | -$8.44B | -$3.65B | -$3.54B | -$2.82B | -$3.03B | -$3.44B | -$3.1B | -$1.21B | -$3.51B | -$4.17B | |
| Balance sheet | Trend | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & equivalents | $1.18B | $1.67B | $2.65B | $3.11B | $5.99B | $6.8B | $10.5B | $10.4B | $4.57B | $5.09B | |
| Short-term investments | $251M | $423M | $518M | $699M | $671M | $730M | $275M | $849M | $1.55B | $1.52B | |
| Receivables | $235M | $386M | $410M | $634M | $885M | $1.14B | $1.44B | $1.56B | $1.61B | $2.05B | |
| Inventory | $77.6M | $112M | $124M | $168M | $281M | $353M | $461M | $739M | $1.21B | $1.69B | |
| Other current assets | $47.8M | $0 | $0 | $0 | $79.7M | $104M | $122M | $86.1M | $207M | $749M | |
| Current assets | $1.83B | $2.65B | $3.84B | $4.82B | $8.13B | $9.56B | $13.2B | $14.1B | $9.6B | $11.2B | |
| Property, plant & equipment (net) | $698M | $789M | $812M | $833M | $1.28B | $1.42B | $1.46B | $1.45B | $2.58B | $3.08B | |
| Long-term investments | $20.3M | $20.4M | $0 | $0 | $0 | $0 | $112M | $2.5B | $5.11B | $5.81B | |
| Goodwill | $50.4M | $50.4M | $50.4M | $1B | $1B | $1B | $1.09B | $1.09B | $1.09B | $1.09B | |
| Intangible assets | $284M | $29M | $0 | $400M | $400M | $400M | $604M | $840M | $826M | $424M | |
| Deferred tax assets | $0 | $834K | $1.5B | $1.19B | $883M | $935M | $1.25B | $1.81B | $2.33B | $3.4B | |
| Other non-current assets | $11.9M | $6.95M | $40.7M | $69.4M | $49.3M | $111M | $410M | $895M | $999M | $1.14B | |
| Non-current assets | $1.07B | $897M | $2.4B | $3.5B | $3.62B | $3.87B | $4.92B | $8.59B | $12.9B | $14.9B | |
| Total assets | $2.89B | $3.55B | $6.25B | $8.32B | $11.8B | $13.4B | $18.2B | $22.7B | $22.5B | $26.1B | |
| Liabilities | |||||||||||
| Accounts payable | $61.5M | $74M | $111M | $87.6M | $155M | $195M | $304M | $365M | $413M | $462M | |
| Accrued expenses | $268M | $603M | $815M | $946M | $1.14B | $1.27B | $1.79B | $2.32B | $352M | $398M | |
| Short-term debt | $300M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $92.3M | $82.8M | |
| Taxes payable | $6.88M | $0 | $0 | $72.3M | $104M | $211M | $123M | $99.5M | $161M | $0 | |
| Deferred revenue | $79.4M | $238M | $24.9M | $62.3M | $192M | $172M | $160M | $170M | $207M | $172M | |
| Other current liabilities | $10.9M | -$203M | $20.3M | $29.2M | $83.5M | $16.5M | $62.5M | $50.7M | $2.5B | $2.75B | |
| Current liabilities | $793M | $807M | $1.12B | $1.33B | $1.88B | $2.14B | $2.74B | $3.55B | $3.56B | $3.86B | |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.85B | |
| Lease obligations (non-current) | $521M | $584M | $582M | $623M | $890M | $887M | $810M | $725M | $1.66B | $1.95B | |
| Deferred revenue (non-current) | $80.1M | $78.4M | $82.6M | $88.8M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Deferred tax liabilities | $134M | $6.34M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.31B | |
| Other non-current liabilities | $30.6M | $27.8M | $26.3M | $187M | $298M | $303M | $686M | $878M | $902M | -$1.49B | |
| Non-current liabilities | $766M | $696M | $690M | $898M | $1.19B | $1.19B | $1.5B | $1.6B | $2.56B | $3.62B | |
| Total liabilities | $1.56B | $1.5B | $1.81B | $2.23B | $3.07B | $3.33B | $4.24B | $5.15B | $6.12B | $7.48B | |
| Equity | |||||||||||
| Common stock & paid-in capital | $2.45M | $2.51M | $2.55M | $2.59M | $2.6M | $2.5M | $2.6M | $2.6M | $2.6M | $2.5M | |
| Retained earnings | -$5.37B | -$5.12B | -$2.99B | -$1.85B | $859M | $3.2B | $6.52B | $10.1B | $9.61B | $13.6B | |
| Accumulated other comprehensive income | $21.2M | -$11.6M | $659K | -$1.97M | -$68.5M | $15.9M | $800K | -$14.3M | $128M | -$15.9M | |
| Shareholders' equity | $1.16B | $2.03B | $4.44B | $6.09B | $8.69B | $10.1B | $13.9B | $17.6B | $16.4B | $18.7B | |
| Debt | |||||||||||
| Total debt (incl. leases) | $841M | $606M | $587M | $662M | $932M | $967M | $900M | $808M | $1.75B | $3.88B | |
| Net debt (debt - cash) | -$343M | -$1.06B | -$2.06B | -$2.45B | -$5.06B | -$5.83B | -$9.6B | -$9.56B | -$2.82B | -$1.21B | |
Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Cash, investments and debt
quarter endsThe other statements
Sources
Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-01